| Room 101 (Main lecture)/ GDR 1 and GDR 5 (Meet the professor and speaker) | ||
| 08:30-08:40 | Opening ceremony Jong Young Choi ( President of the Korean Liver Cancer Association) | |
| Congratulatory message Tim Meyer (President of the International Liver Cancer Association) | ||
| 08:40-10:00 | Symposium 1. Translating science of liver cancer, from the Lab to the Clinic Jessica Zucman-Rossi (Univ. Paris Descartes, France), Young Nyun Park (Yonsei Univ., Korea) | |
| 08:40-08:55 | Exploring tumor microenvironment and immunology in HCC Pil Soo Sung (The Catholic Univ. of Korea, Korea) | |
| 08:55-09:10 | The oncogenomic landscape in HCC Sun Young Yim (Korea Univ., Korea) | |
| 09:10-09:25 | Pathological and molecular features of HCC and CCC Haeryoung Kim (Seoul National Univ., Korea) | |
| 09:25-09:40 | Molecular features and classification of iCCC and combined HCC-CCC Hyun Goo Woo (Ajou Univ., Korea) | |
| 09:40-10:00 | Meet the professor and speaker (Discussion with Q and A) | |
| Room A (GDR 1): Jessica Zucman-Rossi (Univ. Paris Descartes, France), Joong-Won Park (Myongji Hospital, Korea) with speakers | ||
| Room B (GDR 5): Young Nyun Park (Yonsei Univ., Korea), Moon Seok Choi (Sungkyunkwan Univ., Korea) with speakers | ||
| 10:00-11:20 | Symposium 2. Challenges for systemic treatment of advanced HCC Jong Young Choi (The Catholic Univ. of Korea, Korea), Tim Meyer (Univ. College London, UK) | |
| 10:00-10:15 | What is the best option for advanced HCC?: second-line and sequential therapy Bo Hyun Kim (National Cancer Center, Korea) | |
| 10:15-10:30 | Can we predict treatment response in the era of immuno-oncology? Do Young Kim (Yonsei Univ., Korea) | |
| 10:30-10:45 | How to expect and manage the adverse events of immunotherapy? Wonseok Kang (Sungkyunkwan Univ., Korea) | |
| 10:45-11:00 | How to Boost TKI Efficacy in Advanced HCC with Combination Therapies Ju Hyun Shim (Univ. of Ulsan, Korea) | |
| 11:00-11:20 | Meet the professor and speaker (Discussion with Q and A) | |
| Room A (GDR 1): Jong Young Choi (The Catholic Univ. of Korea, Korea), Tim Meyer (Univ. College London, UK) with speakers | ||
| Room B (GDR 5): Lorenza Rimassa (Humanitas Univ., Italy), Ho Yeong Lim (Sungkyunkwan Univ., Korea) with speakers | ||
| 11:20-11:40 | Coffee break | |
| 11:40-12:40 | Symposium 3. Updated imaging and post treatment management of HCC Jeong Min Lee (Seoul National Univ., Korea), Young Seok Kim (Soonchunhyang Univ., Korea) | |
| 11:40-11:55 | What are the current and future trends in imaging diagnosis of HCC? So Yeon Kim (Univ. of Ulsan, Korea) | |
| 11:55-12:10 | Imaging-based prediction of prognosis for HCC Seung Baek Hong (Pusan National Univ., Korea) | |
| 12:10-12:25 | Surveillance and post-treatment response evaluation Eun Sun Jang (Seoul National Univ., Korea) | |
| 12:25-12:40 | Optimal medical care to improve outcomes after HCC treatment Sung Won Lee (The Catholic Univ. of Korea, Korea) | |
| 12:40-13:40 | Lunch break | |
| 13:40-14:40 | Symposium 4. Advances in locoregional treatment of HCC Jin Wook Chung (Seoul National Univ., Korea), Jinsil Seong (Yonsei Univ., Korea) | |
| 13:40-13:55 | Evolving role of TACE in the intermediate-stage HCC: good or poor responders? Dongho Hyun (Sungkyunkwan Univ., Korea) | |
| 13:55-14:10 | Transarterial radioembolization for HCC: patient selection and assessment Hyo-Cheol Kim (Seoul National Univ., Korea) | |
| 14:10-14:25 | Evolution of radiotherapy for HCC: balancing tumor control and hepatic function preservation Sang Min Yoon (Univ. of Ulsan, Korea) | |
| 14:25-14:40 | Particle beam radiotherapy: best indications for HCC Tae Hyun Kim (National Cancer Center, Korea) | |
| 14:40-15:40 | Symposium 5. Pioneering surgical strategies and local ablation for liver cancer Hee Chul Yu (Jeonbuk National Univ., Korea), Young Joon Lee (The Catholic Univ. of Korea, Korea) | |
| 14:40-14:55 | Minimally invasive liver resection for HCC and CCC Dong-Sik Kim (Korea Univ., Korea) | |
| 14:55-15:10 | Liver Transplantation in HCC and CCC: Expanding Indications Dong Jin Joo (Yonsei Univ., Korea) | |
| 15:10-15:25 | Clinical decision in borderline lesions for local ablation therapy Dong Ho Lee (Seoul National Univ., Korea) | |
| 15:25-15:40 | Role of local ablation therapy as a bridge for curative therapy Joon-Il Choi (The Catholic Univ. of Korea, Korea) | |
| 15:40-16:00 | Coffee break | |
| 16:00-17:00 | Tumor board with experts of liver cancer - Session in Korean Discussant: Si Hyun Bae (The Catholic Univ. of Korea, Korea), Kyung Sik Kim (Yonsei Univ., Korea), Hyunchul Rhim (Sungkyunkwan Univ., Korea), Jin Wook Chung (Seoul National Univ., Korea), Jinsil Seong (Yonsei Univ., Korea) Moderator: Hyun Phil Shin (Kyung Hee Univ., Korea) | |
| 16:00-16:20 | HCC with Intermediate stage Jung Hee Kim (Hallym Univ., Korea) | |
| 16:20-16:40 | HCC with vascular invasion Young-Sun Lee (Korea Univ., Korea) | |
| 16:40-17:00 | HCC with metastasis Sangyoun Hwang (Dongnam Inst. of Radiological ＆ Medical Sciences, Korea) | |
| 17:00-17:10 | Closing remarks and acknowledgement of the Korean Liver Cancer Association Jong Young Choi ( President of the Korean Liver Cancer Association) | |
2024
ILCA School Programme
